Dan Fowler

Group Manager, Reprocessing and Sterilization Validation Services

Expertise Areas:

FDA, Microbiology, Preclinical, Regulatory, Validation

Related Services:

Dan Fowler joined NAMSA in March 2025 after the acquisition of WuXi AppTec’s U.S. Medical Device Testing operations. He had been with WuXi AppTec since 2017 and now serves as Group Manager for Reprocessing and Sterilization Validation Services, supporting medical devices, biologics, and combination products.

With over 20 years of experience in medical device third-party reprocessing, Mr. Fowler is an expert in interpreting and applying AAMI TIR30. He oversees sterilization modalities, including radiation, moist heat (gravity and prevacuum), ethylene oxide (EO), and dry heat. His expertise enables him to streamline the identification and validation of analytical laboratory assays and establish best practices in method development for inoculation/extractions and effective cleaning and disinfection strategies for reusable medical devices. Additionally, he is a member of the AAMI Sterilization Standards Committee.

Reserve your Consultation with our Experts

Contact Us